BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 21098225)

  • 21. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.
    den Haan JM; Lehar SM; Bevan MJ
    J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation.
    Ding Y; Guo Z; Liu Y; Li X; Zhang Q; Xu X; Gu Y; Zhang Y; Zhao D; Cao X
    Nat Immunol; 2016 Oct; 17(10):1167-75. PubMed ID: 27548433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.
    Jirmo AC; Nagel CH; Bohnen C; Sodeik B; Behrens GM
    J Immunol; 2009 Jan; 182(1):283-92. PubMed ID: 19109159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction.
    Chougnet CA; Thacker RI; Shehata HM; Hennies CM; Lehn MA; Lages CS; Janssen EM
    J Immunol; 2015 Sep; 195(6):2624-32. PubMed ID: 26246142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo.
    Schuurhuis DH; Ioan-Facsinay A; Nagelkerken B; van Schip JJ; Sedlik C; Melief CJ; Verbeek JS; Ossendorp F
    J Immunol; 2002 Mar; 168(5):2240-6. PubMed ID: 11859111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active dissemination of cellular antigens by DCs facilitates CD8
    Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
    Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
    Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
    Front Immunol; 2018; 9():2775. PubMed ID: 30542351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
    Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
    J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type.
    Smyth LA; Harker N; Turnbull W; El-Doueik H; Klavinskis L; Kioussis D; Lombardi G; Lechler R
    J Immunol; 2008 Sep; 181(5):3212-20. PubMed ID: 18713992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells.
    Qu C; Nguyen VA; Merad M; Randolph GJ
    J Immunol; 2009 Mar; 182(6):3650-9. PubMed ID: 19265143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
    Wang Y; Da'Dara AA; Thomas PG; Harn DA
    Immunology; 2010 Mar; 129(3):406-17. PubMed ID: 19922421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
    Warren TL; Bhatia SK; Acosta AM; Dahle CE; Ratliff TL; Krieg AM; Weiner GJ
    J Immunol; 2000 Dec; 165(11):6244-51. PubMed ID: 11086059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo.
    Schliehe C; Redaelli C; Engelhardt S; Fehlings M; Mueller M; van Rooijen N; Thiry M; Hildner K; Weller H; Groettrup M
    J Immunol; 2011 Sep; 187(5):2112-21. PubMed ID: 21795597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
    Boross P; van Montfoort N; Stapels DA; van der Poel CE; Bertens C; Meeldijk J; Jansen JH; Verbeek JS; Ossendorp F; Wubbolts R; Leusen JH
    J Immunol; 2014 Dec; 193(11):5506-14. PubMed ID: 25355925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivered antigen peptides to resident CD8α
    Wang L; Wang Z; Qin Y; Liang W
    Eur J Pharm Biopharm; 2020 Feb; 147():76-86. PubMed ID: 31887349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes.
    Cruz-Leal Y; Grubaugh D; Nogueira CV; Lopetegui-González I; Del Valle A; Escalona F; Laborde RJ; Alvarez C; Fernández LE; Starnbach MN; Higgins DE; Lanio ME
    Front Immunol; 2018; 9():2473. PubMed ID: 30455685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.